Within a few weeks, perhaps before many Americans finish decorating for the holidays, the U.S. could have access to a new antiviral pill from Merck expected to alter the deadly trajectory of the covid-19 pandemic — with a second option from Pfizer to follow shortly after.

The post Success Of Covid Antiviral Pills Hinges On Access To Speedy And Accurate Tests appeared first on The Seattle Medium.